Gregory K. Bell, Andrew Tepperman, and Justin Ho contributed a chapter to Global Arbitration Review’s The Guide to Damages in International Arbitration. Their chapter, entitled “Damages in Life Sciences Arbitrations,” covers disputes in the life sciences sector, with a focus on the biopharmaceutical industry. The authors outline some of the main types of disputes that are heard in life sciences arbitrations and discuss some of the life sciences-specific aspects of common analyses that are used to determine damages in these types of disputes.
To read more, click the link below.
The year in review: Updates and trends
In 2022, we witnessed intense activity in matters related to supply chain issues, the energy transition, oil & gas, post-M&A disputes, licensing issues,...